RECRUITING

Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)

Conditions

Lung Carcinoma Metastatic Malignant Neoplasm in the Lung

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study evaluates the effectiveness of robotic biopsies in providing information about hereditary or cancer specific genetic variants that may have a role in diagnosis of cancer and to develop genetic results and medical record databank for future studies.

Official Title

Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)

Quick Facts

Study Start:2024-06-24

Study Completion:2027-07-01

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06482073

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* \* Subject age 18 years and older * Subject is scheduled for a bronchoscopy as part of standard of care * Subject with a moderate to high risk of lung cancer based on clinical demographic and radiologic information or with suspected metastatic disease * Ability to provide blood or saliva sample * Enrolled in study IRB#16-009655 * Ability to provide archived tissue * Subject is able to understand and adhere to study requirements and able to provide informed consent	* \* Individuals who have situations that would limit compliance with the study requirements * Institutionalized (i.e. federal medical prison) * Pregnant * Prior germline genetic testing with a 40+ multi-gene panel within the last 1 year of enrollment * Prior somatic tissue (250+ gene) testing within the prior 3 months of enrollment

Inclusion Criteria

Exclusion Criteria

* \* Subject age 18 years and older
* Subject is scheduled for a bronchoscopy as part of standard of care
* Subject with a moderate to high risk of lung cancer based on clinical demographic and radiologic information or with suspected metastatic disease
* Ability to provide blood or saliva sample
* Enrolled in study IRB#16-009655
* Ability to provide archived tissue
* Subject is able to understand and adhere to study requirements and able to provide informed consent

* \* Individuals who have situations that would limit compliance with the study requirements
* Institutionalized (i.e. federal medical prison)
* Pregnant
* Prior germline genetic testing with a 40+ multi-gene panel within the last 1 year of enrollment
* Prior somatic tissue (250+ gene) testing within the prior 3 months of enrollment

Contacts and Locations

Principal Investigator

Janani S. Reisenauer, M.D.

PRINCIPAL_INVESTIGATOR

Mayo Clinic in Rochester

Study Locations (Sites)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905

United States

Collaborators and Investigators

Sponsor: Mayo Clinic

Janani S. Reisenauer, M.D., PRINCIPAL_INVESTIGATOR, Mayo Clinic in Rochester

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-06-24

Study Completion Date2027-07-01

Study Record Updates

Study Start Date2024-06-24

Study Completion Date2027-07-01

Terms related to this study

Additional Relevant MeSH Terms

Lung Carcinoma
Metastatic Malignant Neoplasm in the Lung